Function Following Laser for Anal Intraepithelial Neoplasia (FLAN)
NCT04109573 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2021-08-31
Summary
High-grade squamous intraepithelial lesions (HSIL) and anal cancer are rising in incidence and at highest risk are HIV positive men who have sex with men (MSM). This pilot study assessing anal function and patient-reported outcomes before and after laser ablation of HSIL will add to the evidence that such a therapy is an acceptable and safe treatment to offer in a preventative setting.We will be recruting HIV positive and negative MSM.
Conditions
- Anus Cancer
- Fecal Incontinence
- Anal Intraepithelial Neoplasia
- Post Operative Pain
Interventions
- PROCEDURE
-
high resolution anal manometry
functional studies before and after anal laser ablation
Sponsors & Collaborators
-
Barts & The London NHS Trust
collaborator OTHER -
Homerton University Hospital NHS Foundation Trust
lead OTHER
Principal Investigators
-
Tamzin Cuming, FRCS · Homerton University Hospital NHS Trust
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-01
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection
NCT02437851 ·Status: COMPLETED ·Phase: PHASE2
-
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
NCT04929028 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Fistula-associated Anal Adenocarcinoma
NCT05381324 ·Status: COMPLETED
-
Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer
NCT05868317 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer
NCT01269216 ·Status: COMPLETED ·Phase: PHASE2
-
Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer
NCT02340949 ·Status: COMPLETED ·Phase: PHASE2
-
FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients
NCT02935764 ·Status: UNKNOWN ·Phase: PHASE3
-
Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery
NCT00936832 ·Status: WITHDRAWN ·Phase: PHASE2
-
FOLFOX/FOLFIRI Containing Levofolinic Acid (Zuoyu ®) in the Treatment of Unresectable or Metastatic Colorectal Cancer
NCT05797883 ·Status: UNKNOWN ·Phase: PHASE2
-
Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
NCT00408551 ·Status: UNKNOWN ·Phase: PHASE2
-
First Line Treatment by FOLFIRINOX for Patients With a Rectum Cancer With Synchronous Non Resectable Metastasis
NCT01674309 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)
NCT01046864 ·Status: COMPLETED ·Phase: PHASE1
-
Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
NCT00004142 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer
NCT02785068 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer
NCT00052585 ·Status: TERMINATED ·Phase: PHASE2
-
Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer
NCT00320320 ·Status: TERMINATED ·Phase: PHASE2
-
Phase II Trial of Preoperative High-dose-rate Endorectal Brachytherapy and FOLFOX Chemotherapy for Rectal Cancer
NCT01659424 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma
NCT00168155 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum
NCT00580073 ·Status: TERMINATED ·Phase: PHASE2
-
Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
NCT00080951 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
NCT05382442 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision
NCT02167321 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer
NCT00984048 ·Status: COMPLETED
-
SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed
NCT00002551 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Intratumoral Ipilimumab and TLR4 Agonist GLA-SE in Combination With Systemic Nivolumab and Chemotherapy
NCT03982121 ·Status: WITHDRAWN ·Phase: PHASE1